0001104659-24-042512.txt : 20240402 0001104659-24-042512.hdr.sgml : 20240402 20240402161521 ACCESSION NUMBER: 0001104659-24-042512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fisher Andrew CENTRAL INDEX KEY: 0002014301 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 24814380 MAIL ADDRESS: STREET 1: C/O VERONA PHARMA PLC STREET 2: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2410563-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-04-01 0 0001657312 Verona Pharma plc VRNA 0002014301 Fisher Andrew 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 0 1 0 0 General Counsel 0 Share Options (Right to Buy) 2.0113 2024-04-01 4 A 0 2400000 0 A 2034-03-31 Ordinary Shares 2400000 2400000 D The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. The option vests and becomes exercisable as to 25% on March 4, 2025. The remainder of the shares will vest in 36 equal monthly installments thereafter. /s/ Claire Poll, Attorney-in-Fact for Andrew Fisher 2024-04-02